Principal Scientist I/II for Multi-specific biologics in Oncology Drug Discovery
Novartis
Summary
We are expanding our biotherapeutics team at Novartis and seeking a highly motivated Principal Scientist to join our discovery team and help advance next-generation multispecific biologics for Oncology. This role will focus on identifying and developing novel multispecific therapeutic concepts grounded in strong cancer biology, complex mechanisms of action, and innovative protein engineering principles.
Job description
About the Role
We are expanding our biotherapeutics team at Novartis and seeking a highly motivated Principal Scientist to join our discovery team and help advance next-generation multispecific biologics for Oncology. This role will focus on identifying and developing novel multispecific therapeutic concepts grounded in strong cancer biology, complex mechanisms of action, and innovative protein engineering principles.
Key Responsibilities
- Lead scientific efforts to identify, evaluate, and advance novel multispecific biologic concepts in oncology
- Translate cancer biology, tumor microenvironment biology, and pathway mechanisms into differentiated therapeutic hypotheses
- Partner closely with protein engineering teams to design, optimize, and characterize multispecific biologic formats
- Evaluate complex mechanisms of action, including cell-cell engagement, receptor modulation, immune activation, pathway regulation, or tumor-selective biology
- Design and execute experiments to assess biologic activity, mechanism, selectivity, and translational relevance
- Collaborate cross-functionally with oncology biology, protein engineering, translational sciences, pharmacology, bioinformatics, and development teams
- Integrate internal and external scientific data to inform target selection, molecule design, and program strategy
- Contribute to platform thinking around multispecific biologics, including novel formats, mechanism-driven designs, and differentiated therapeutic concepts
- Present scientific findings and recommendations to project teams, leadership, and external collaborators
- Monitor emerging science and competitive activity in oncology biologics, multispecific platforms, and complex therapeutic mechanisms
Preferred Experience
- Experience advancing oncology biologics from concept through lead optimization or preclinical validation
- Hands-on experience with in vitro oncology assays, functional cell-based assays, co-culture systems, immune-cell assays, receptor biology, or pathway biology
- Familiarity with complex biologic mechanisms such as conditional activation, tumor-localized activity, receptor clustering, immune redirection, or pathway reprogramming
- Experience working closely with protein engineering or antibody discovery teams
- Knowledge of translational oncology, biomarker strategy, patient selection, or resistance mechanisms
- Track record of scientific contributions through publications, patents, presentations, or program advancement
Requirements
- Ph.D. in cancer biology, molecular biology, cell biology, immunology, biochemistry, bioengineering, or a related discipline
- 3–5 years of relevant post-Ph.D. experience, preferably in an industry drug discovery or biologics setting
- Strong background in cancer biology, oncology signaling pathways, tumor microenvironment biology, or immune-oncology
- Experience with protein therapeutics, multispecific biologics, antibody engineering, or biologic drug discovery
- Demonstrated ability to connect disease biology with therapeutic mechanism and molecule design
- Familiarity with protein engineering concepts, multispecific formats, developability considerations, or biologic characterization
- Strong experimental design, data interpretation, and problem-solving skills
- Excellent communication skills and ability to collaborate across biology, engineering, pharmacology, and translational functions
Benefits
- Health Insurance
- Life Insurance
- Disability Benefits
- 401(k) Matching
- Performance-Based Cash Incentive
- Annual Equity Awards
- Vacation
- Personal Days
- Holidays
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.